Oral erythromycin therapy in epidermolysis bullosa simplex generalized severe

Br J Dermatol. 2015 Aug;173(2):563-4. doi: 10.1111/bjd.13672. Epub 2015 Jun 10.
No abstract available

Publication types

  • Clinical Study
  • Letter
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Administration, Oral
  • Anti-Bacterial Agents / administration & dosage*
  • Child
  • Child, Preschool
  • Dermatologic Agents / administration & dosage*
  • Epidermolysis Bullosa Simplex / complications
  • Epidermolysis Bullosa Simplex / drug therapy*
  • Erythromycin / administration & dosage*
  • Female
  • Humans
  • Infant
  • Male
  • Skin Diseases, Bacterial / complications
  • Skin Diseases, Bacterial / drug therapy*
  • Staphylococcal Skin Infections / complications
  • Staphylococcal Skin Infections / drug therapy
  • Staphylococcus aureus
  • Streptococcal Infections / complications
  • Streptococcal Infections / drug therapy
  • Streptococcus
  • Treatment Outcome

Substances

  • Anti-Bacterial Agents
  • Dermatologic Agents
  • Erythromycin